Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab (BV) plus chemotherapy (CT) for platinum (PT)-resistant recurrent ovarian cancer (OC)

Authors :: Rikke Frederiksen
Yan V. Wang
Belén Ojeda
Eric Pujade-Lauraine
Lars Hanker
Amreen Husain
Maarit Anttila
David T. Bollag
Enrico Breda
Peter Vuylsteke
Source :: Journal of Clinical Oncology. 32:5540-5540
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: 5540^ Background: AURELIA is a phase 3, randomized, open-label trial in patients (pts) with PT-resistant, recurrent OC (NCT00976911). Based on investigator (INV) assessment of radiographic data, CT...

Subjects :: Cancer Research
medicine.medical_specialty
Chemotherapy
Bevacizumab
business.industry
medicine.medical_treatment
Surgery
Oncology
Recurrent Ovarian Cancer
medicine
In patient
Radiology
business
medicine.drug

Tools